Delayed release aspirin for vascular obstruction prophylaxis
OwnerAlvin S. Bluminventor
Life of this patent
Estimating the term…
Loading patent…
OwnerAlvin S. Bluminventor
Estimating the term…
A method and controlled release oral unit dosage form of acetylsalicylic acid (aspirin) delays the release of the drug until a predetermined time interval after ingestion. This enables the drug to reach optimal therapeutic blood levels at a time in the early morning when the events leading up to a vascular obstruction culminating in a heart attack or stroke are most commonly occurring after the drug is taken in the evening. The convenience of taking the drug every evening should enhance compliance. By arranging for the optimal blood level to coincide with the peak incidence of strokes, a much smaller total dose of the drug may be used than is normally prescribed. This may reduce the incidence of side effects that are dose related. This will make the prophylactic use of aspirin available to more of the population.
A controlled release pharmaceutical composition in oral unit dosage form for releasing aspirin into the gastrointestinal tract in absorbable form at a predetermined time interval after ingestion and not before, the dosage form comprising:
A method of providing a blood level of aspirin that does not begin to rise until a predetermined time interval of at least five hours after ingestion of a unit dosage form, the method comprising:
A controlled release pharmaceutical composition in oral unit dosage form for releasing a drug into the gastrointestinal tract at a predetermined time interval after ingestion and not before, the unit dosage form comprising:
Dependencies are inferred from the claim text.